Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Indian Journal of Pathology & Microbiology|November 10, 2015
Lymphoepithelioma-like hepatocellular carcinoma without Epstein-Barr virus infection: A case report and a review of the literatureJianguo Wei, Qingmeng Liu, Cheng Wang, et al.
Molecular Pharmaceutics|October 7, 2024
Responsive Supramolecular Nanomicelles Formed through Self-Assembly of Acyclic Cucurbit[n]uril for Targeted Drug Delivery to Cancer CellsYamin Li, Qingmeng Liu, Jiawei Ding, et al.
Frontiers in Public Health|January 31, 2022
No Alteration Between Intrinsic Connectivity Networks by a Pilot Study on Localized Exposure to the Fourth-Generation Wireless Communication SignalsLei Yang, Qingmeng Liu, Yu Zhou, et al.
Nanomaterials (Basel, Switzerland)|December 17, 2024
Advances and Challenges in Tracking Interactions Between Plants and Metal-Based NanoparticlesKena Zhang, Qingmeng Liu, Yukun Wang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 23, 2014
[Relationship between CT findings and immunohistochemical types of gastrointestinal stromal tumors]Hongwei Xu, Qingmeng Liu, Xiuyi Zhu, et al.
Journal of Hazardous Materials|December 31, 2025
Environmentally relevant PFOS exposures reveal low phytotoxicity yet high bioaccumulation in model cropsYukun Wang, Shenqing Wang, Hongwei Liang, et al.
Food Chemistry|September 1, 2023
Inclusion complexes of capsanthin with acyclic cucurbit[n]urils to improve its stability and antioxidant capacityYamin Li, Jiawei Zhou, Lutao Wang, et al.
Scientific Reports|February 13, 2023
Ki67 increase after core needle biopsy associated with worse disease outcome in HER2-negative breast cancer patientsYiwei Tong, Jiangfeng Dai, Jiahui Huang, et al.
ACS Nano|August 21, 2025
Harnessing Nanotechnology for Cellular Health through Strategic Modulation and Nanoscale Control of Electron MobilityJinhao Yao, Shenqing Wang, Chaofan Deng, et al.
Frontiers in Immunology|May 16, 2025
Complete remission of a high-risk, locally advanced cervical cancer with para-aortic lymph node metastases treated with first-line tislelizumab plus bevacizumab combined with chemotherapy followed by radiotherapy with maintenance therapy: a case reportJuan Lang, Qianqian Liu, Rong Ji, et al.
Pageof 2